T-lymphocyte activation antigen CD80
| GO Term | Evidence Code | Reference |
|---|---|---|
| negative regulation of T cell mediated immunity | ||
| immune response | ||
| cell surface receptor signaling pathway | ||
| positive regulation of signal transduction | ||
| T cell costimulation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| virus receptor activity |
|
|
| coreceptor activity | ||
| coreceptor activity | ||
| receptor ligand activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 53 |
|
|
||
| 89 |
|
|
||
| 98 |
|
|
||
| 144 |
|
|
||
| 186 |
|
|
||
| 207 |
|
|||
| 211 |
|
|
||
| 226 |
|
|
||
| 232 |
|
|
| Pathway Name | Organism |
|---|---|
| CD28 co-stimulation | Homo sapiens |
| CD28 dependent PI3K/Akt signaling | Homo sapiens |
| CD28 dependent Vav1 pathway | Homo sapiens |
| Co-inhibition by CTLA4 | Homo sapiens |
| Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
| Interleukin-10 signaling | Homo sapiens |
| PI3K/AKT Signaling | Homo sapiens |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9744 | type 1 diabetes mellitus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026